Clinical significance of the mesorectal extension of rectal cancer: A Japanese multi-institutional study

Annals of Surgery

Volumn 253, Issue 4, 2011, Pages 704-710

  Shirouzu, Kazuo ^a   Akagi, Yoshito ^a   Fujita, Shin ^b   Ueno, Hideki ^c   Takii, Yasumasa ^d   Komori, Koji ^e   Ito, Masaaki ^f   Sugihara, Kenichi ^g  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d NIIGATA CANCER CENTER HOSPITAL   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f National Cancer Center   (Japan)

^g TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANCE OF THE MESORECTAL EXTENSION; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; RECTUM CARCINOMA; RISK ASSESSMENT; TUMOR VOLUME;

ADULT; AGED; BIOPSY, NEEDLE; COHORT STUDIES; COLECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROCTOSCOPY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 79953181204     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182119331     Document Type: Article

References (24)

1. Hermanek P, Henson DE, Hutter RVP, et al, eds. UICC TNM Supplement. Berlin, Heidelberg, New York: Springer; 1993.
2. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet. 1990;1:1055-1059. (Pubitemid 20148648)
3. Willett CG, Badizadegan K, Ancukiewicz M, et al. Prognostic factor in Stage T3N0. Do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum. 1999;42:167-173. (Pubitemid 29085151)
4. Merkel S, Mansmann U, Siassi M, et al. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis. 2001;16:298-304. (Pubitemid 32927002)
5. Steel MC, Woods R, Mackay JM, et al. Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. Anz J Surg. 2002;72: 483-487. (Pubitemid 34779377)
6. Picon AI, Moore HG, Sternberg SS, et al. Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis. 2003;18:487-492. (Pubitemid 37265859)
7. Miyoshi M, Ueno H, Hashiguchi Y, et al. Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg. 2006;243:492-497.
8. Katsumata D, Fukui H, Ono Y, et al. Depth of tumor invasion in locally advanced rectal cancer correlates with patients' prognosis: the usefulness of elastic stain for its measurement. Surg Today. 2008;38:115-122. (Pubitemid 351197903)
9. Yoshida K, Yoshimatsu K, Otani T, et al. The depth of invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer. Anticancer Res. 2008;28:1773-1778. (Pubitemid 351892883)
10. Tokoro T, Okuno K, Hida J, et al. Depth of mesorectal invasion has prognositic significance in T3N0 low rectal cancer. Hepato-Gastroenterology 2009;56:124-127.
11. Wittekind C, Greene FL, Henson DE, eds. UICC TNM Supplement: A Commentary on Uniform Use. 3rd ed. New York: Wiley-Liss; 2003.
12. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma (2nd English ed). Tokyo, Japan: Kanehara & Co Ltd; 2009.
13. Sobin LH,Wittekind C, eds. UICC TNM Classification ofMalignant Tumours. 6th ed. New York: Wiley-Liss; 2002.
14. Green FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
15. Jessup JM, Stewart AK, Menck HR. The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985-1995. Cancer. 1998;83:2408-2418. (Pubitemid 28533512)
16. Williams NS, Jass JR, Hardcastle JD. Clinicopathological assessment and staging of colorectal cancer. Br J Surg. 1988;75:649-652.
17. Harewood GC, Kumar KS, Clain JE, et al. Clinical implications of quantifi- cation of mesorectal tumor invasion by endoscopic ultrasound: all T3 rectal cancers are not equal. J Gastro Hepatol. 2004;19:750-755. (Pubitemid 38981395)
18. Enker WE, Thaler HT, Cranor ML, et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J AmColl Surg. 1995;181:335-346.
19. Law WL, Ho JWC, Chan R, et al. Outcome of anterior resection for Stage II rectal cancer without radiation-the role of adjuvant chemotherapy. Dis Colon Rectum. 2005;48:218-226. (Pubitemid 40576550)
20. Zaheer S, Pemberton JH, Farouk R, et al. Surgical treatment of adenocarcinoma of the rectum. Ann Surg. 1998;227:800-811. (Pubitemid 29119527)
21. Merchant NB, Guillem JG, Paty PB, et al. T3N0 rectal cancer-results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg. 1999;3:642-647.
22. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980-987.
23. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. The Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
24. Wittekind C, Compton C, Quirke P, et al. A uniformresidual tumor (R) classifi- cation: integration of the R classification and the circumference margin status. Cancer. 2009;115:3483-3488.